{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:21:59Z","timestamp":1793060519152,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001078","name":"Diabetes Research Institute Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40259-025-00703-7","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:00:11Z","timestamp":1738918811000},"page":"261-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1177-5333","authenticated-orcid":false,"given":"Arthur","family":"Rech Tondin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-4803","authenticated-orcid":false,"given":"Giacomo","family":"Lanzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"10","key":"703_CR1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741\u201360.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"703_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/00015458.2008.11680243","volume":"108","author":"JP Squifflet","year":"2008","unstructured":"Squifflet JP, Gruessner RW, Sutherland DE. The history of pancreas transplantation: past, present and future. Acta Chir Belg. 2008;108(3):367\u201378.","journal-title":"Acta Chir Belg"},{"issue":"4","key":"703_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2337\/diab.37.4.413","volume":"37","author":"C Ricordi","year":"1988","unstructured":"Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes. 1988;37(4):413\u201320.","journal-title":"Diabetes"},{"issue":"13","key":"703_CR4","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa061267","volume":"355","author":"AM Shapiro","year":"2006","unstructured":"Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318\u201330.","journal-title":"N Engl J Med"},{"issue":"11","key":"703_CR5","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.2337\/db16-0234","volume":"65","author":"C Ricordi","year":"2016","unstructured":"Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, et al. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes. 2016;65(11):3418\u201328.","journal-title":"Diabetes"},{"issue":"7","key":"703_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S2213-8587(18)30078-0","volume":"6","author":"S Lablanche","year":"2018","unstructured":"Lablanche S, Vantyghem MC, Kessler L, Wojtusciszyn A, Borot S, Thivolet C, et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2018;6(7):527\u201337.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"703_CR7","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","volume":"39","author":"BJ Hering","year":"2016","unstructured":"Hering BJ, Clarke WR, Bridges ND, Eggerman TL, Alejandro R, Bellin MD, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2016;39(7):1230\u201340.","journal-title":"Diabetes Care"},{"issue":"4","key":"703_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/ajt.16174","volume":"21","author":"JF Markmann","year":"2021","unstructured":"Markmann JF, Rickels MR, Eggerman TL, Bridges ND, Lafontant DE, Qidwai J, et al. Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. Am J Transplant. 2021;21(4):1477\u201392.","journal-title":"Am J Transplant"},{"issue":"12","key":"703_CR9","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2337\/dc21-2688","volume":"45","author":"MR Rickels","year":"2022","unstructured":"Rickels MR, Eggerman TL, Bayman L, Qidwai JC, Alejandro R, Bridges ND, et al. Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study. Diabetes Care. 2022;45(12):2967\u201375.","journal-title":"Diabetes Care"},{"issue":"11","key":"703_CR10","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nbt1259","volume":"24","author":"KA D'Amour","year":"2006","unstructured":"D\u2019Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24(11):1392\u2013401.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"703_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443\u201352.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"703_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"5","key":"703_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"37","key":"703_CR14","doi-asserted-by":"publisher","first-page":"15768","DOI":"10.1073\/pnas.0906894106","volume":"106","author":"R Maehr","year":"2009","unstructured":"Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009;106(37):15768\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"703_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203126","volume":"13","author":"SM Southard","year":"2018","unstructured":"Southard SM, Kotipatruni RP, Rust WL. Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. PLoS ONE. 2018;13(9): e0203126.","journal-title":"PLoS ONE"},{"issue":"10","key":"703_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224944","volume":"14","author":"SM Southard","year":"2019","unstructured":"Southard SM, Kotipatruni RP, Rust WL. Correction: Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. PLoS ONE. 2019;14(10): e0224944.","journal-title":"PLoS ONE"},{"issue":"2","key":"703_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, Ryu JH, et al. Generation of functional human pancreatic beta cells in vitro. Cell. 2014;159(2):428\u201339.","journal-title":"Cell"},{"issue":"4","key":"703_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stemcr.2015.02.017","volume":"4","author":"MC Nostro","year":"2015","unstructured":"Nostro MC, Sarangi F, Yang C, Holland A, Elefanty AG, Stanley EG, et al. Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Reports. 2015;4(4):591\u2013604.","journal-title":"Stem Cell Reports."},{"key":"703_CR19","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1038\/ncomms11463","volume":"7","author":"JR Millman","year":"2016","unstructured":"Millman JR, Xie C, Van Dervort A, Gurtler M, Pagliuca FW, Melton DA. Generation of stem cell-derived beta-cells from patients with type 1 diabetes. Nat Commun. 2016;7:11463.","journal-title":"Nat Commun"},{"key":"703_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.635405","volume":"12","author":"K Molakandov","year":"2021","unstructured":"Molakandov K, Berti DA, Beck A, Elhanani O, Walker MD, Soen Y, et al. Selection for CD26(-) and CD49A(+) Cells From Pluripotent Stem Cells-Derived Islet-Like Clusters Improves Therapeutic Activity in Diabetic Mice. Front Endocrinol (Lausanne). 2021;12: 635405.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"703_CR21","doi-asserted-by":"publisher","first-page":"13608","DOI":"10.1038\/s41598-024-64346-4","volume":"14","author":"A Jeyagaran","year":"2024","unstructured":"Jeyagaran A, Urbanczyk M, Layland SL, Weise F, Schenke-Layland K. Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA. Sci Rep. 2024;14(1):13608.","journal-title":"Sci Rep"},{"issue":"8","key":"703_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108067","volume":"32","author":"P Augsornworawat","year":"2020","unstructured":"Augsornworawat P, Maxwell KG, Velazco-Cruz L, Millman JR. Single-Cell Transcriptome Profiling Reveals beta Cell Maturation in Stem Cell-Derived Islets after Transplantation. Cell Rep. 2020;32(8): 108067.","journal-title":"Cell Rep"},{"issue":"9","key":"703_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.stem.2023.08.001","volume":"30","author":"J Wang","year":"2023","unstructured":"Wang J, Sun S, Deng H. Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives. Cell Stem Cell. 2023;30(9):1130\u201347.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"703_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","volume":"28","author":"Y Du","year":"2022","unstructured":"Du Y, Liang Z, Wang S, Sun D, Wang X, Liew SY, et al. Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. Nat Med. 2022;28(2):272\u201382.","journal-title":"Nat Med"},{"issue":"1","key":"703_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s42255-022-00713-7","volume":"5","author":"Z Liang","year":"2023","unstructured":"Liang Z, Sun D, Lu S, Lei Z, Wang S, Luo Z, et al. Implantation underneath the abdominal anterior rectus sheath enables effective and functional engraftment of stem-cell-derived islets. Nat Metab. 2023;5(1):29\u201340.","journal-title":"Nat Metab"},{"issue":"22","key":"703_CR26","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","volume":"187","author":"S Wang","year":"2024","unstructured":"Wang S, Du Y, Zhang B, Meng G, Liu Z, Liew SY, et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell. 2024;187(22):6152-64.e18.","journal-title":"Cell"},{"issue":"711","key":"703_CR27","doi-asserted-by":"publisher","first-page":"eadf6376","DOI":"10.1126\/scitranslmed.adf6376","volume":"15","author":"IJ Anwar","year":"2023","unstructured":"Anwar IJ, Berman DM, DeLaura I, Gao Q, Willman MA, Miller A, et al. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates. Sci Transl Med. 2023;15(711):eadf6376.","journal-title":"Sci Transl Med."},{"issue":"11","key":"703_CR28","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.4049\/jimmunol.1003266","volume":"187","author":"ES Yolcu","year":"2011","unstructured":"Yolcu ES, Zhao H, Bandura-Morgan L, Lacelle C, Woodward KB, Askenasy N, et al. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice. J Immunol. 2011;187(11):5901\u20139.","journal-title":"J Immunol"},{"issue":"12","key":"703_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","volume":"19","author":"R Lanza","year":"2019","unstructured":"Lanza R, Russell DW, Nagy A. Engineering universal cells that evade immune detection. Nat Rev Immunol. 2019;19(12):723\u201333.","journal-title":"Nat Rev Immunol"},{"issue":"7830","key":"703_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","volume":"586","author":"E Yoshihara","year":"2020","unstructured":"Yoshihara E, O\u2019Connor C, Gasser E, Wei Z, Oh TG, Tseng TW, et al. Immune-evasive human islet-like organoids ameliorate diabetes. Nature. 2020;586(7830):606\u201311.","journal-title":"Nature"},{"issue":"9","key":"703_CR31","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.stemcr.2022.08.002","volume":"17","author":"E Sintov","year":"2022","unstructured":"Sintov E, Nikolskiy I, Barrera V, Hyoje-Ryu Kenty J, Atkin AS, Gerace D, et al. Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets. Stem Cell Reports. 2022;17(9):1976\u201390.","journal-title":"Stem Cell Reports."},{"issue":"1","key":"703_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100879","volume":"4","author":"D Gerace","year":"2023","unstructured":"Gerace D, Zhou Q, Kenty JH, Veres A, Sintov E, Wang X, et al. Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance. Cell Rep Med. 2023;4(1): 100879.","journal-title":"Cell Rep Med."},{"issue":"3","key":"703_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","volume":"31","author":"X Hu","year":"2024","unstructured":"Hu X, White K, Young C, Olroyd AG, Kievit P, Connolly AJ, et al. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate. Cell Stem Cell. 2024;31(3):334-40e5.","journal-title":"Cell Stem Cell"},{"key":"703_CR34","doi-asserted-by":"crossref","unstructured":"Hu X, White K, Young C, Olroyd AG, Kievit P, Connolly A, et al. 333-OR: Hypoimmune islet cells mediate insulin independence after allogeneic transplantation in a fully immunocompetent nonhuman primate without immunosuppression. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-333-OR"},{"issue":"11","key":"703_CR35","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1111\/ajt.16693","volume":"21","author":"NS Kenyon","year":"2021","unstructured":"Kenyon NS, Willman MA, Han D, Leeman RS, Rabassa A, Diaz WL, et al. Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timing. Am J Transplant. 2021;21(11):3524\u201337.","journal-title":"Am J Transplant"},{"key":"703_CR36","doi-asserted-by":"crossref","unstructured":"Gooch A, Westenfelder C. 334-OR: Allogeneic neo-islets reduce insulin need by up to 1.2 U\/kg bw in autoimmune type 1 diabetes dogs over three years without requiring antirejection drugs, enough to meet human type 1 diabetes mellitus needs. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-334-OR"},{"issue":"3","key":"703_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.scr.2014.03.003","volume":"12","author":"K Kirk","year":"2014","unstructured":"Kirk K, Hao E, Lahmy R, Itkin-Ansari P. Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. Stem Cell Res. 2014;12(3):807\u201314.","journal-title":"Stem Cell Res"},{"issue":"7","key":"703_CR38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3727\/096368912X657486","volume":"22","author":"M Kumagai-Braesch","year":"2013","unstructured":"Kumagai-Braesch M, Jacobson S, Mori H, Jia X, Takahashi T, Wernerson A, et al. The TheraCyte device protects against islet allograft rejection in immunized hosts. Cell Transplant. 2013;22(7):1137\u201346.","journal-title":"Cell Transplant"},{"issue":"9","key":"703_CR39","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1517\/14712598.2015.1055242","volume":"15","author":"AA Tomei","year":"2015","unstructured":"Tomei AA, Villa C, Ricordi C. Development of an encapsulated stem cell-based therapy for diabetes. Expert Opin Biol Ther. 2015;15(9):1321\u201336.","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"703_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100466","volume":"2","author":"AMJ Shapiro","year":"2021","unstructured":"Shapiro AMJ, Thompson D, Donner TW, Bellin MD, Hsueh W, Pettus J, et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Rep Med. 2021;2(12): 100466.","journal-title":"Cell Rep Med."},{"key":"703_CR41","doi-asserted-by":"crossref","unstructured":"Butler PC, Gale EA. Reversing type 1 diabetes with stem cell-derived islets: a step closer to the dream? J Clin Invest. 2022;132(3)42:1507\u20131514","DOI":"10.1172\/JCI158305"},{"key":"703_CR42","doi-asserted-by":"crossref","unstructured":"Keymeulen B, De Groot K, Jacobs-Tulleneers-Thevissen D, Thompson DM, Bellin MD, Kroon EJ, et al. Encapsulated stem cell-derived beta cells exert glucose control in patients with type 1 diabetes. Nat Biotechnol. 2024 Oct;42(10):1507-1514.","DOI":"10.1038\/s41587-023-02055-5"},{"issue":"5","key":"703_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MPA.0000000000001050","volume":"47","author":"H Komatsu","year":"2018","unstructured":"Komatsu H, Kandeel F, Mullen Y. Impact of Oxygen on Pancreatic Islet Survival. Pancreas. 2018;47(5):533\u201343.","journal-title":"Pancreas"},{"issue":"11","key":"703_CR44","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.1113560109","volume":"109","author":"E Pedraza","year":"2012","unstructured":"Pedraza E, Coronel MM, Fraker CA, Ricordi C, Stabler CL. Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc Natl Acad Sci U S A. 2012;109(11):4245\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"703_CR45","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/ajt.14642","volume":"18","author":"PO Carlsson","year":"2018","unstructured":"Carlsson PO, Espes D, Sedigh A, Rotem A, Zimerman B, Grinberg H, et al. Transplantation of macroencapsulated human islets within the bioartificial pancreas betaAir to patients with type 1 diabetes mellitus. Am J Transplant. 2018;18(7):1735\u201344.","journal-title":"Am J Transplant"},{"issue":"18","key":"703_CR46","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1111\/jcmm.17499","volume":"26","author":"HP Dang","year":"2022","unstructured":"Dang HP, Chen H, Dargaville TR, Tuch BE. Cell delivery systems: Toward the next generation of cell therapies for type 1 diabetes. J Cell Mol Med. 2022;26(18):4756\u201367.","journal-title":"J Cell Mol Med"},{"issue":"12S1","key":"703_CR47","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/01.tp.0000804420.88438.67","volume":"105","author":"P Bachul","year":"2021","unstructured":"Bachul P, Generette GS, Perez-Gutierrez A, Borek P, Wang L-J, Golab K, et al. 307.5: modified approach allowed for improved islet allotransplantation into pre-vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I\/II Clinical Trial at University of Chicago. Transplantation. 2021;105(12S1):S25.","journal-title":"Transplantation"},{"issue":"3","key":"703_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas AJ, Veiseh O, Gurtler M, Millman JR, Pagliuca FW, Bader AR, et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med. 2016;22(3):306\u201311.","journal-title":"Nat Med"},{"key":"703_CR49","unstructured":"Thanos C, Lavin DM, Bintz BE, Bhatnagar D, Mills J, Billings M, inventorsCELL HOUSING DEVICE2019."},{"key":"703_CR50","doi-asserted-by":"publisher","first-page":"204173142110277","DOI":"10.1177\/20417314211027714","volume":"12","author":"EX Han","year":"2021","unstructured":"Han EX, Wang J, Kural M, Jiang B, Leiby KL, Chowdhury N, et al. Development of a Bioartificial Vascular Pancreas. J Tissue Eng. 2021;12:20417314211027710.","journal-title":"J Tissue Eng"},{"key":"703_CR51","doi-asserted-by":"crossref","unstructured":"Kural MH, Nash KM, Naegeli KM, Qian H, Wang J, Kirkton RD, et al. 335-OR: Preliminary Results of Islet Survival in a Novel Biovascular Pancreas Implanted in Primates. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-335-OR"},{"issue":"19","key":"703_CR52","doi-asserted-by":"publisher","first-page":"eabm9881","DOI":"10.1126\/sciadv.abm9881","volume":"8","author":"J Lei","year":"2022","unstructured":"Lei J, Coronel MM, Yolcu ES, Deng H, Grimany-Nuno O, Hunckler MD, et al. FasL microgels induce immune acceptance of islet allografts in nonhuman primates. Sci Adv. 2022;8(19):eabm9881.","journal-title":"Sci Adv"},{"key":"703_CR53","doi-asserted-by":"crossref","unstructured":"Rech Tondin A, Yolcu ES, Herring SK, Hester DM, Gadea Y, Vega G, et al. 2024-LB: Reversal of Diabetes by Human Stem Cell\u2013Derived Islets Implanted with an Immunomodulatory Microgel in a Retrievable Site. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-2024-LB"},{"key":"703_CR54","doi-asserted-by":"crossref","unstructured":"Stover H. 226-OR: Immunoprivileged Hydrogels Recover Normoglycemia for Extended Duration in Immunocompetent Diabetic Animals. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-226-OR"},{"key":"703_CR55","doi-asserted-by":"crossref","unstructured":"Espona-Noguera A, Ciriza J, Canibano-Hernandez A, Orive G, Hernandez RMM, Saenz Del Burgo L, et al. Review of advanced hydrogel-based cell encapsulation systems for insulin delivery in type 1 diabetes mellitus. Pharmaceutics. 2019;11(11).","DOI":"10.3390\/pharmaceutics11110597"},{"key":"703_CR56","doi-asserted-by":"crossref","unstructured":"Kavand A, Noverraz F, Gerber-Lemaire S. Recent advances in alginate-based hydrogels for cell transplantation applications. Pharmaceutics. 2024;16(4).","DOI":"10.3390\/pharmaceutics16040469"},{"issue":"11","key":"703_CR57","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41551-018-0275-1","volume":"2","author":"MA Bochenek","year":"2018","unstructured":"Bochenek MA, Veiseh O, Vegas AJ, McGarrigle JJ, Qi M, Marchese E, et al. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques. Nat Biomed Eng. 2018;2(11):810\u201321.","journal-title":"Nat Biomed Eng."},{"issue":"47","key":"703_CR58","doi-asserted-by":"publisher","first-page":"19054","DOI":"10.1073\/pnas.1317561110","volume":"110","author":"B Ludwig","year":"2013","unstructured":"Ludwig B, Reichel A, Steffen A, Zimerman B, Schally AV, Block NL, et al. Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A. 2013;110(47):19054\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8903","key":"703_CR59","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S0140-6736(94)90067-1","volume":"343","author":"P Soon-Shiong","year":"1994","unstructured":"Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet. 1994;343(8903):950\u20131.","journal-title":"Lancet"},{"issue":"32","key":"703_CR60","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1016\/j.biomaterials.2006.07.010","volume":"27","author":"P de Vos","year":"2006","unstructured":"de Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials. 2006;27(32):5603\u201317.","journal-title":"Biomaterials"},{"issue":"7","key":"703_CR61","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/ajt.15308","volume":"19","author":"DA Alagpulinsa","year":"2019","unstructured":"Alagpulinsa DA, Cao JJL, Driscoll RK, Sirbulescu RF, Penson MFE, Sremac M, et al. Alginate-microencapsulation of human stem cell-derived beta cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression. Am J Transplant. 2019;19(7):1930\u201340.","journal-title":"Am J Transplant"},{"key":"703_CR62","doi-asserted-by":"crossref","unstructured":"Wang LH, Ernst AU, Flanders JA, Liu W, Wang X, Datta AK, et al. An inverse-breathing encapsulation system for cell delivery. Sci Adv. 2021;7(20).","DOI":"10.1126\/sciadv.abd5835"},{"issue":"6","key":"703_CR63","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nbt.2580","volume":"31","author":"L Zhang","year":"2013","unstructured":"Zhang L, Cao Z, Bai T, Carr L, Ella-Menye JR, Irvin C, et al. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol. 2013;31(6):553\u20136.","journal-title":"Nat Biotechnol"},{"issue":"29","key":"703_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202202596","volume":"18","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Wei T, Ge R, Li Q, Liu B, Ji Z, et al. microfluidic production of zwitterion coating microcapsules with low foreign body reactions for improved islet transplantation. Small. 2022;18(29): e2202596.","journal-title":"Small"},{"issue":"1","key":"703_CR65","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1038\/s41467-019-13238-7","volume":"10","author":"Q Liu","year":"2019","unstructured":"Liu Q, Chiu A, Wang LH, An D, Zhong M, Smink AM, et al. Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation. Nat Commun. 2019;10(1):5262.","journal-title":"Nat Commun"},{"issue":"8","key":"703_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202104899","volume":"18","author":"W Liu","year":"2022","unstructured":"Liu W, Flanders JA, Wang LH, Liu Q, Bowers DT, Wang K, et al. A safe, fibrosis-mitigating, and scalable encapsulation device supports long-term function of insulin-producing cells. Small. 2022;18(8): e2104899.","journal-title":"Small"},{"issue":"26","key":"703_CR67","doi-asserted-by":"publisher","first-page":"eabm3145","DOI":"10.1126\/sciadv.abm3145","volume":"8","author":"AA Stock","year":"2022","unstructured":"Stock AA, Gonzalez GC, Pete SI, De Toni T, Berman DM, Rabassa A, et al. Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates. Sci Adv. 2022;8(26):eabm3145.","journal-title":"Sci Adv"},{"issue":"4","key":"703_CR68","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2337\/db14-0070","volume":"64","author":"R Razavi","year":"2015","unstructured":"Razavi R, Najafabadi HS, Abdullah S, Smukler S, Arntfield M, van der Kooy D. Diabetes enhances the proliferation of adult pancreatic multipotent progenitor cells and biases their differentiation to more beta-cell production. Diabetes. 2015;64(4):1311\u201323.","journal-title":"Diabetes"},{"issue":"9","key":"703_CR69","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/stem.1460","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang Y, Lanzoni G, Carpino G, Cui CB, Dominguez-Bendala J, Wauthier E, et al. Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis. Stem Cells. 2013;31(9):1966\u201379.","journal-title":"Stem Cells"},{"issue":"1","key":"703_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/hep.28326","volume":"64","author":"G Lanzoni","year":"2016","unstructured":"Lanzoni G, Cardinale V, Carpino G. The hepatic, biliary, and pancreatic network of stem\/progenitor cell niches in humans: A new reference frame for disease and regeneration. Hepatology. 2016;64(1):277\u201386.","journal-title":"Hepatology"},{"issue":"11","key":"703_CR71","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.cmet.2023.10.001","volume":"35","author":"M Doke","year":"2023","unstructured":"Doke M, Alvarez-Cubela S, Klein D, Altilio I, Schulz J, Mateus Goncalves L, et al. Dynamic scRNA-seq of live human pancreatic slices reveals functional endocrine cell neogenesis through an intermediate ducto-acinar stage. Cell Metab. 2023;35(11):1944\u201360.","journal-title":"Cell Metab"},{"key":"703_CR72","doi-asserted-by":"crossref","unstructured":"Darden C, Kuncha J, Mattke JD, Lawrence MC, Naziruddin B. 223-OR: Characterization of Regenerative Adult Islet Progenitor Cells from Human Pancreatic Tissue. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-223-OR"},{"issue":"1","key":"703_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-023-01707-x","volume":"9","author":"K Al-Hasani","year":"2024","unstructured":"Al-Hasani K, Marikar SN, Kaipananickal H, Maxwell S, Okabe J, Khurana I, et al. EZH2 inhibitors promote beta-like cell regeneration in young and adult type 1 diabetes donors. Signal Transduct Target Ther. 2024;9(1):2.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"703_CR74","doi-asserted-by":"publisher","first-page":"eabk1826","DOI":"10.1126\/sciadv.abk1826","volume":"8","author":"X Ma","year":"2022","unstructured":"Ma X, Lu Y, Zhou Z, Li Q, Chen X, Wang W, et al. Human expandable pancreatic progenitor-derived beta cells ameliorate diabetes. Sci Adv. 2022;8(8):eabk1826.","journal-title":"Sci Adv"},{"issue":"6987","key":"703_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature02520","volume":"429","author":"Y Dor","year":"2004","unstructured":"Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429(6987):41\u20136.","journal-title":"Nature"},{"key":"703_CR76","doi-asserted-by":"crossref","unstructured":"Ackeifi C, Wang P, Karakose E, Manning Fox JE, Gonzalez BJ, Liu H, et al. GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration. Sci Transl Med. 2020;12(530).","DOI":"10.1126\/scitranslmed.aaw9996"},{"issue":"755","key":"703_CR77","doi-asserted-by":"publisher","first-page":"eadg3456","DOI":"10.1126\/scitranslmed.adg3456","volume":"16","author":"C Rosselot","year":"2024","unstructured":"Rosselot C, Li Y, Wang P, Alvarsson A, Beliard K, Lu G, et al. Harmine and exendin-4 combination therapy safely expands human beta cell mass in vivo in a mouse xenograft system. Sci Transl Med. 2024;16(755):eadg3456.","journal-title":"Sci Transl Med."},{"key":"703_CR78","unstructured":"Administration USFaD. FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes 2023 [Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cellular-therapy-treat-patients-type-1-diabetes. Accessed Jul 7 2024."},{"issue":"1","key":"703_CR79","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11845-023-03464-w","volume":"193","author":"M Affan","year":"2024","unstructured":"Affan M, Dar MS. Donislecel-the first approved pancreatic islet cell therapy medication for type 1 diabetes: a letter to the editor. Ir J Med Sci. 2024;193(1):231\u20132.","journal-title":"Ir J Med Sci"},{"issue":"2","key":"703_CR80","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/cd23-0091","volume":"42","author":"O Giri","year":"2024","unstructured":"Giri O, Goldman JD. Donislecel: First Cellular Therapy to Treat Patients With Brittle Type 1 Diabetes. Clin Diabetes. 2024;42(2):337\u201340.","journal-title":"Clin Diabetes."},{"key":"703_CR81","doi-asserted-by":"crossref","unstructured":"Rios P, Mcgarrigle JJ, Lamonica G, Li Y, Cook J, Joshi I, et al. 35-OR: Lantidra, First FDA-approved cellular therapy to treat type 1 diabetes. Diabetes. 2024;73(Supplement_1).","DOI":"10.2337\/db24-35-OR"},{"issue":"12","key":"703_CR82","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","volume":"28","author":"A Ramzy","year":"2021","unstructured":"Ramzy A, Thompson DM, Ward-Hartstonge KA, Ivison S, Cook L, Garcia RV, et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell. 2021;28(12):2047\u201361.","journal-title":"Cell Stem Cell"},{"key":"703_CR83","unstructured":"(NLM) TNLoM. A phase 1\/2 study to evaluate the safety, tolerability, and efficacy of VX-880 in subjects who have type 1 diabetes mellitus with impaired hypoglycemic awareness and severe hypoglycemia 2021 ["},{"key":"703_CR84","doi-asserted-by":"crossref","unstructured":"Markmann JF, Naji A, Rickels MR, Alba M, Marigowda G, Ross L, et al. 259-OR: stem cell\u2013derived, fully differentiated islet cells for type 1 diabetes. Diabetes. 2022;71(Supplement_1).","DOI":"10.2337\/db22-259-OR"},{"key":"703_CR85","doi-asserted-by":"crossref","unstructured":"Reichman TW, Ricordi C, Naji A, Markmann JF, Perkins BA, Wijkstrom M, et al. 836-P: Glucose-dependent insulin production and insulin-independence in type 1 diabetes from stem cell\u2013derived, fully differentiated islet cells\u2014updated data from the VX-880 clinical trial. Diabetes. 2023;72(Supplement_1).","DOI":"10.2337\/db23-836-P"},{"key":"703_CR86","doi-asserted-by":"crossref","unstructured":"Karpov DS, Sosnovtseva AO, Pylina SV, Bastrich AN, Petrova DA, Kovalev MA, et al. Challenges of CRISPR\/Cas-based cell therapy for type 1 diabetes: how not to engineer a \"Trojan Horse\". Int J Mol Sci. 2023;24(24).","DOI":"10.3390\/ijms242417320"},{"issue":"11","key":"703_CR87","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.ymthe.2023.10.011","volume":"31","author":"CL Stabler","year":"2023","unstructured":"Stabler CL, Russ HA. Regulatory approval of islet transplantation for treatment of type 1 diabetes: implications and what is on the horizon. Mol Ther. 2023;31(11):3107\u20138.","journal-title":"Mol Ther"},{"key":"703_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.789526","volume":"12","author":"P Witkowski","year":"2021","unstructured":"Witkowski P, Philipson LH, Buse JB, Robertson RP, Alejandro R, Bellin MD, et al. Islets transplantation at a crossroads-need for urgent regulatory update in the United States: perspective presented during the Scientific Sessions 2021 at the American Diabetes Association Congress. Front Endocrinol (Lausanne). 2021;12: 789526.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"703_CR89","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/ajt.16397","volume":"21","author":"P Witkowski","year":"2021","unstructured":"Witkowski P, Philipson LH, Kaufman DB, Ratner LE, Abouljoud MS, Bellin MD, et al. The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021;21(4):1365\u201375.","journal-title":"Am J Transplant"},{"key":"703_CR90","doi-asserted-by":"publisher","first-page":"1375177","DOI":"10.3389\/fimmu.2024.1375177","volume":"15","author":"BX Ho","year":"2024","unstructured":"Ho BX, Teo AKK, Ng NHJ. Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation. Front Immunol. 2024;15:1375177.","journal-title":"Front Immunol"},{"key":"703_CR91","doi-asserted-by":"publisher","first-page":"10575","DOI":"10.3389\/ti.2022.10575","volume":"35","author":"S Pellegrini","year":"2022","unstructured":"Pellegrini S, Zamarian V, Sordi V. Strategies to Improve the Safety of iPSC-Derived \u03b2 Cells for \u03b2 Cell Replacement in Diabetes. Transpl Int. 2022;35:10575.","journal-title":"Transpl Int"},{"issue":"2","key":"703_CR92","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.stem.2020.07.004","volume":"27","author":"J Harding","year":"2020","unstructured":"Harding J, Vintersten-Nagy K, Nagy A. Universal Stem Cells: Making the Unsafe Safe. Cell Stem Cell. 2020;27(2):198\u20139.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"703_CR93","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2337\/db15-1525","volume":"65","author":"DM Berman","year":"2016","unstructured":"Berman DM, Molano RD, Fotino C, Ulissi U, Gimeno J, Mendez AJ, et al. Bioengineering the endocrine pancreas: intraomental islet transplantation within a biologic resorbable scaffold. Diabetes. 2016;65(5):1350\u201361.","journal-title":"Diabetes"},{"issue":"11","key":"703_CR94","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/labinvest.2010.124","volume":"90","author":"A Pisania","year":"2010","unstructured":"Pisania A, Weir GC, O\u2019Neil JJ, Omer A, Tchipashvili V, Lei J, et al. Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest. 2010;90(11):1661\u201375.","journal-title":"Lab Invest"},{"issue":"7","key":"703_CR95","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.2337\/diabetes.51.7.2148","volume":"51","author":"EA Ryan","year":"2002","unstructured":"Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes. 2002;51(7):2148\u201357.","journal-title":"Diabetes"},{"issue":"4","key":"703_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102580","volume":"4","author":"SD Pollock","year":"2023","unstructured":"Pollock SD, Galicia-Silva IM, Liu M, Gruskin ZL, Alvarez-Dominguez JR. Scalable generation of 3D pancreatic islet organoids from human pluripotent stem cells in suspension bioreactors. STAR Protoc. 2023;4(4): 102580.","journal-title":"STAR Protoc."},{"issue":"4","key":"703_CR97","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41591-022-01718-1","volume":"28","author":"L Zhan","year":"2022","unstructured":"Zhan L, Rao JS, Sethia N, Slama MQ, Han Z, Tobolt D, et al. Pancreatic islet cryopreservation by vitrification achieves high viability, function, recovery and clinical scalability for transplantation. Nat Med. 2022;28(4):798\u2013808.","journal-title":"Nat Med"},{"issue":"5","key":"703_CR98","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.medj.2022.04.004","volume":"3","author":"K Scheibner","year":"2022","unstructured":"Scheibner K, Lickert H. Awaking sleeping islets for a cure of diabetes. Med. 2022;3(5):279\u201380.","journal-title":"Med"},{"issue":"4","key":"703_CR99","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5966\/sctm.2014-0110","volume":"4","author":"JA Heslop","year":"2015","unstructured":"Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, et al. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med. 2015;4(4):389\u2013400.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"703_CR100","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.stemcr.2022.03.004","volume":"17","author":"Y Aghazadeh","year":"2022","unstructured":"Aghazadeh Y, Sarangi F, Poon F, Nkennor B, McGaugh EC, Nunes SS, et al. GP2-enriched pancreatic progenitors give rise to functional beta cells in vivo and eliminate the risk of teratoma formation. Stem Cell Reports. 2022;17(4):964\u201378.","journal-title":"Stem Cell Reports."},{"issue":"5","key":"703_CR101","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.stem.2023.04.002","volume":"30","author":"NJ Hogrebe","year":"2023","unstructured":"Hogrebe NJ, Ishahak M, Millman JR. Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell. 2023;30(5):530\u201348.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"703_CR102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00400857","volume":"35","author":"GL Warnock","year":"1992","unstructured":"Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(1):89\u201395.","journal-title":"Diabetologia"},{"issue":"1","key":"703_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00007691-200502000-00008","volume":"27","author":"AM Shapiro","year":"2005","unstructured":"Shapiro AM, Gallant HL, Hao EG, Lakey JR, McCready T, Rajotte RV, et al. The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit. 2005;27(1):35\u20137.","journal-title":"Ther Drug Monit"},{"issue":"691","key":"703_CR104","doi-asserted-by":"publisher","first-page":"eadg5794","DOI":"10.1126\/scitranslmed.adg5794","volume":"15","author":"X Hu","year":"2023","unstructured":"Hu X, Gattis C, Olroyd AG, Friera AM, White K, Young C, et al. Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice. Sci Transl Med. 2023;15(691):eadg5794.","journal-title":"Sci Transl Med."}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-025-00703-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40259-025-00703-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-025-00703-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:18:19Z","timestamp":1741835899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40259-025-00703-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1007\/s40259-025-00703-7","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"5 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was supported by the Diabetes Research Institute Foundation at the University of Miami. The authors acknowledge the critical support and resources provided by these institutions, which have significantly contributed to the advancement of this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the University of Miami or the Diabetes Research Institute Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The list of references is presented in full.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material Data Availability"}},{"value":"Not applicable as no datasets were generated or analyzed for this review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data\u00a0Sharing"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Both authors have reviewed and approved the final manuscript and consent to its publication.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"ART: Conceptualization, research, analysis, and writing of the review. GL: Conceptualization, analysis, writing, and editing of the review.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}